3E0Q305Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach
- Billable / Specific Code
3E0Q305 is a billable ICD-10-PCS procedure code for Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 023, 024. The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Operation | 0 | Introduction |
| 4 | BodySystem/Region | Q | Cranial Cavity and Brain |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | 0 | Antineoplastic |
| 7 | Qualifier | 5 | Other Antineoplastic |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for 3E0Q305 under the General Equivalence Mappings.
Code History
- 3E0Q005 — Introduce Oth Antineoplastic in Cran Cav/Brain, Open
Similar Procedure Codes
Questions About 3E0Q305
Is 3E0Q305 a billable code?
Yes. 3E0Q305 is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in 3E0Q305 mean?
3E0Q305 breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character Q is the BodySystem/Region (Cranial Cavity and Brain); the 5th character 3 is the Approach (Percutaneous); the 6th character 0 is the Substance (Antineoplastic); the 7th character 5 is the Qualifier (Other Antineoplastic).
What MS-DRG does 3E0Q305 group to?
On an inpatient stay, Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach maps to MS-DRGs 023, 024, with relative weights from 3.9119 to 5.7303. The MS-DRG sets the fixed Medicare payment for the stay.
What is the ICD-9-PCS equivalent of 3E0Q305?
Under the General Equivalence Mappings, Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach crosswalks to ICD-9-PCS 10. The mapping is approximate, so confirm it fits the documentation.
